Biohub, the nonprofit biomedical research organization backed by Mark Zuckerberg and Priscilla Chan, is launching a $1.8 billion effort to expand biological data intended for training AI models. The initiative, often described as the “Virtual Biology Initiative,” aims to help researchers analyze and predict how cells behave, with the goal of supporting new approaches to preventing and treating disease.
Multiple outlets report that the funding brings together Biohub with US government organizations, including the U.S. Department of Energy (DOE) and the National Institutes of Health (NIH), alongside technology and life-sciences players. Google DeepMind and Meta are also part of the effort, joined by AI drug discovery startup Isomorphic Labs. Reuters-backed reporting cited by The Verge and others says these private partners collectively invest $300 million, complementing the broader government-linked contribution.
Outlets characterize the stakes differently: some focus on the scale of the dataset-building push, while others highlight the potential downstream impact on AI-assisted research and drug development timelines. Across coverage, the common point is the creation of open or shared datasets meant to make it easier for researchers to apply AI models to biological and cellular questions.
